Scorpius Holdings Faces Delisting Concerns
Ticker: SCPX · Form: 8-K · Filed: Apr 30, 2024 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | Apr 30, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0002 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, compliance
Related Tickers: SCPX
TL;DR
SCPX might get delisted from Nasdaq - big trouble ahead.
AI Summary
Scorpius Holdings, Inc. (formerly HEAT BIOLOGICS, INC. and NightHawk Biosciences, Inc.) filed an 8-K on April 30, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates potential issues with meeting Nasdaq's continued listing requirements as of April 29, 2024.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could lead to the company's stock being removed from Nasdaq, impacting investor liquidity and valuation.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to trade on a major exchange, posing a significant risk to its operations and shareholder value.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- HEAT BIOLOGICS, INC. (company) — Former Company Name
- NightHawk Biosciences, Inc. (company) — Former Company Name
- April 29, 2024 (date) — Date of earliest event reported
- April 30, 2024 (date) — Date of Report
FAQ
What specific listing rule or standard has Scorpius Holdings, Inc. failed to satisfy?
The filing states it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify which rule was violated in the provided text.
What is the earliest event date reported in this 8-K filing?
The earliest event date reported is April 29, 2024.
What were the previous names of Scorpius Holdings, Inc.?
Scorpius Holdings, Inc. was formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.
On what date was this 8-K form filed?
This 8-K form was filed on April 30, 2024.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a notice of delisting or failure to satisfy a continued listing rule or standard.
Filing Stats: 558 words · 2 min read · ~2 pages · Grade level 13.4 · Accepted 2024-04-30 08:00:10
Key Financial Figures
- $0.0002 — nge on which registered Common Stock, $0.0002 par value per share SCPX NYSE America
Filing Documents
- scpx_8k.htm (8-K) — 27KB
- 0001079973-24-000617.txt ( ) — 238KB
- scpx-20240429.xsd (EX-101.SCH) — 3KB
- scpx-20240429_def.xml (EX-101.DEF) — 26KB
- scpx-20240429_lab.xml (EX-101.LAB) — 36KB
- scpx-20240429_pre.xml (EX-101.PRE) — 25KB
- scpx_8k_htm.xml (XML) — 5KB
01 Notice of Delisting
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing. On April 29, 2024, Scorpius Holdings, Inc. (the "Company") received a notice (the "Notice") from NYSE Regulation (the "Notice") stating that the Company has now regained compliance with Section 1007 of the NYSE American Company Guide as a result of its filing of its Annual Report on Form 10-K for the year ended December 31, 2023 on April 26, 2024. As previously reported, on April 17, 2024, the Company received a notice from NYSE Regulation that the Company was not on such date in compliance with the continued listing standards of the NYSE American LLC under the timely filing criteria included in Section 1007 of the NYSE American Company Guide because the Company had failed to timely file its Annual Report on Form 10-K for the year ended December 31, 2023, which was due to be filed with the Securities and Exchange Commission no later than April 16, 2024.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibits are filed with this Current Report on Form 8-K: Exhibit Number Description 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 30, 2024 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer